# Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia

> **NCT00623935** · PHASE2 · COMPLETED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 56 (actual)

## Conditions studied

- Acute Myelogenous Leukemia

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Busulfan
- **RADIATION:** Total Body Irradiation
- **PROCEDURE:** Stem Cell Transplant

## Key facts

- **NCT ID:** NCT00623935
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2013-06
- **Final completion:** 2015-11
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00623935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00623935, "Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00623935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*